InMed Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.649; its P/E ratio is -0.18; InMed Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 1.24M	$ 901.86K	$ 2.31M	$ 1.03M	$ 469.78K
Gross Profit	$ 324.14K	$ 21.24K	$ 1.30M	$ 192.51K	$ 131.16K
EBIT	$ -1.48M	$ -2.54M	$ -336.59K	$ -2.00M	$ -2.10M
EBITDA	$ -1.33M	$ -2.39M	$ -185.62K	$ -1.85M	$ -1.95M
Net Income Common Stockholders	$ -1.48M	$ -2.54M	$ -338.39K	$ -2.00M	$ -2.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 9.58M	$ 6.78M	$ 8.96M	$ 9.65M	$ 11.50M
Total Assets	$ 15.26M	$ 10.92M	$ 14.11M	$ 14.73M	$ 16.92M
Total Debt	$ 1.17M	$ 293.00K	$ 391.71K	$ 496.37K	$ 598.21K
Net Debt	$ -8.41M	$ -6.49M	$ -8.57M	$ -9.15M	$ -10.90M
Total Liabilities	$ 2.48M	$ 1.34M	$ 2.02M	$ 2.34M	$ 2.58M
Stockholders Equity	$ 12.77M	$ 9.58M	$ 12.09M	$ 12.39M	$ 14.34M
Cash Flow	-
Free Cash Flow	$ -1.86M	$ -2.17M	$ -817.95K	$ -6.63M	$ -2.71M
Operating Cash Flow	$ -1.85M	$ -2.17M	$ -657.93K	$ -6.63M	$ -2.71M
Investing Cash Flow	$ -9.29K	-	$ -33.61K	$ -628.20K	$ -500.00K
Financing Cash Flow	$ 4.65M	-	-	$ 10.68M	$ 5.32M

Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

Income Statement >

InMed Pharmaceuticals Debt to Assets

Balance Sheet >

InMed Pharmaceuticals Cash Flow

Cash Flow >

InMed Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing